New CEO Joins Newly Selected Executive Officers to Optimize US Organization
IRVINE, Calif. – Feb. 21, 2019 – Nihon Kohden, a U.S. market leader in precision medical products and services, today announced the appointment of Yasuhiro Yoshitake as its new president and CEO. Yoshitake is taking over the helm of the organization from Dr. Wilson P. Constantine, who led the organization from April 2015 to February 2019.
Yoshitake’s appointment coincides with the realignment of U.S. leadership, including the developmentof three new positions to optimize the organization for continued growth. The new positions – a chief operations officer, a chief financial officer and a chief commercial officer – as well as the company’schief technology officer, will report directly to Yoshitake.
“The U.S. is a dynamic healthcare market that requires deep collaboration between the corporateheadquarters in Japan and the U.S. organization,” said Hirokazu Ogino, president and CEO of Nihon Kohden Corporation. “Yoshitake’s understanding of Nihon Kohden and deep experience around the world will allow us to continue to build our presence and facilitate growth in the U.S.”
Yoshitake first joined Nihon Kohden in 1988. He has held key positions in multiple regions around the world, including Europe and China, as well as in Asia and Middle East operations. Most recently, he served as Nihon Kohden’s general manager of international operations and corporate director and operating officer, which are positions that he will retain as part of his new role.
As part of the realignment, several structural shifts have been made across the organization, including:
Harsh Dharwad will continue in his role as vice president and chief technology officer reporting to Yoshitake.
Scott Iserman has been promoted to chief commercial officer and will be responsible for the commercial strategy, and for building a commercialization infrastructure and organization that drives business growth and market share.
Shinya Hama has been promoted to chief operations officer, responsible for effective operations of the business, including delivery of products and services, overall quality and utilization of resources to ensure efficiency.
Kenji Sakai joined the organization as chief financial officer, responsible for identifying and evaluating new business opportunities to funnel our growth, providing financial direction on larger more complex transactions, and providing leadership to the finance department.
“The American healthcare market is a significant part of Nihon Kohden’s future,” Yoshitake said. “We believe these shifts will allow us to continue building upon the significant growth Nihon Kohden has secured in the last few years and position us to achieve our goal of further growing our share of the market.”
About Nihon Kohden Corporation
Founded in Japan in 1951, Nihon Kohden is a leading manufacturer, developer and distributor of medical electronic equipment, with subsidiaries in the U.S., Europe and Asia. The company’s products are now used in more than 120 countries, and it is the largest supplier of electroencephalography products worldwide. A pioneer in transformational healthcare technology, Nihon Kohden has envisioned, designed and produced revolutionary devices, such as pulse oximeters, arrhythmia analysis, low-invasive blood volume monitoring and wireless patient monitoring. In the U.S., the company is a trusted source for patient monitoring, sleep assessment, neurology and cardiology instrumentation solutions, and has been rated No. 1 in patient monitoring or telemetry for more than 10 consecutive years (MD Buyline). For more information, visit us.nihonkohden.com.
MD Buyline is a registered service mark of MD Buyline.
Senior Director, Communications and Public Relations 949-238-4869